KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Change in Taxes (2016 - 2020)

Supernus Pharmaceuticals (SUPN) has disclosed Change in Taxes for 5 consecutive years, with -$25.1 million as the latest value for Q3 2020.

  • Quarterly Change in Taxes fell 1268.42% to -$25.1 million in Q3 2020 from the year-ago period, while the trailing twelve-month figure was -$4.9 million through Sep 2020, down 31.72% year-over-year, with the annual reading at -$9.9 million for FY2019, 178.97% down from the prior year.
  • Change in Taxes for Q3 2020 was -$25.1 million at Supernus Pharmaceuticals, down from $15.9 million in the prior quarter.
  • The five-year high for Change in Taxes was $15.9 million in Q2 2020, with the low at -$25.1 million in Q3 2020.
  • Average Change in Taxes over 5 years is -$5000.0, with a median of $782000.0 recorded in 2016.
  • The sharpest move saw Change in Taxes surged 7481.82% in 2017, then crashed 24176.12% in 2018.
  • Over 5 years, Change in Taxes stood at -$804000.0 in 2016, then skyrocketed by 1275.25% to $9.4 million in 2017, then crashed by 59.48% to $3.8 million in 2018, then plummeted by 162.03% to -$2.4 million in 2019, then crashed by 954.78% to -$25.1 million in 2020.
  • According to Business Quant data, Change in Taxes over the past three periods came in at -$25.1 million, $15.9 million, and $6.7 million for Q3 2020, Q2 2020, and Q1 2020 respectively.